Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > Arrowhead Research Units to Combine

January 19th, 2008

Arrowhead Research Units to Combine

Abstract:
Nanotechnology developer Arrowhead Research Corp. said Friday its subsidiary Calando Pharmaceuticals Inc. will become part of another of its subsidiaries, Insert Therapeutics Inc.

Arrowhead said as part of the deal, the subsidiaries will be recapitalized to eliminate their preferred stock.

At Insert, each preferred share will be converted into one common share, the company said. At Calando, each preferred share will be converted into one Calando common share.

The company said shareholders of Calando stock will receive Insert shares at an exchange ratio of about 5.97 shares of Insert stock for each Calando share. Outstanding options to buy Calando stock will be converted into an option to buy about 5.97 shares of Insert stock.

Source:
money.cnn.com

Bookmark:

Related News Press

News and information

Kinks and curves at the nanoscale: New research shows 'perfect twin boundaries' are not so perfect May 20th, 2013

Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013

NanoInk, Inc. Assets To Be Sold May 18th, 2013

Artificial Forest for Solar Water-Splitting: Berkeley Lab Researchers Report First Fully Integrated Artificial Photosynthesis Nanosystem May 17th, 2013

Nanomedicine

Nanotechnology could help fight diabetes: Injectable nanogel can monitor blood-sugar levels and secrete insulin when needed May 16th, 2013

Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013

Pitt Chemists Demonstrate Nanoscale Alloys So Bright They Could Have Potential Medical Applications: “Think about a particle that will not only help researchers detect cancer sooner but be used to treat the tumor, too.” May 15th, 2013

Using clay to grow bone: Researchers use synthetic silicate to stimulate stem cells into bone cells May 15th, 2013

Announcements

Kinks and curves at the nanoscale: New research shows 'perfect twin boundaries' are not so perfect May 20th, 2013

Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013

NanoInk, Inc. Assets To Be Sold May 18th, 2013

Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013

Acquisitions/Mergers/Splits

Mincom Capital Inc. and Group Nanoxplore Inc. Sign Letter of Intent for a Qualifying Transaction April 10th, 2013

SUNY NanoCollege and Children's Museum of Science and Technology Announce Agreement for CMOST to Become Part of CNSE: Under CNSE’s leadership, museum will be transformed into a flagship science center to educate in the emerging 21st century science and engineering disciplines February 6th, 2013

Lumineq plant now world’s largest ALD-enabled product factory February 4th, 2013

Nanostart AG reorganizes Asia business: Focus on Asian markets - Launch of 100-percent subsidiary February 4th, 2013